secwatch.observer — SEC 8-K summary
======================================

Issuer:     InnovAge Holding Corp. (INNV)
CIK:        0001834376
Form:       8-K
Filed at:   2022-06-30T23:59:59+00:00
Accession:  0001104659-22-076315
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InnovAge appoints James Carlson as non-executive Chairman effective June 30, 2022
--------------------------------------------------------------------------------

- Carlson will serve as Class II director and Chairman until the 2023 annual meeting.
- Received RSU grant worth $125,000 (vests in one year) plus annual retainers totaling $200,000.
- Previously CEO of Amerigroup (sold to WellPoint for ~$5B) and EVP at UnitedHealth Group.
- Board expands from nine to ten directors; Carlson is independent.
- Andrew Cavanna steps down as Chairman; Carlson selected under shareholder nomination agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834376/000110465922076315/0001104659-22-076315-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834376/000110465922076315/tm2220116d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-076315

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer